Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort

B. Balcan (Istanbul, Turkey), J. Newitt (Pittsburgh, United States of America), S. M Nouraie (Pittsburgh, United States of America), P. J Strollo (Pittsburgh, United States of America), E. Thunström (Gothenburg, Sweden), Y. Peker (Istanbul, Turkey)

Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Session: Diagnostic characteristics and consequences of sleep and breathing disorders
Session type: Oral Presentation
Number: 4994
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Balcan (Istanbul, Turkey), J. Newitt (Pittsburgh, United States of America), S. M Nouraie (Pittsburgh, United States of America), P. J Strollo (Pittsburgh, United States of America), E. Thunström (Gothenburg, Sweden), Y. Peker (Istanbul, Turkey). Clinical and polysomnographic determinants of REM predominant obstructive sleep apnoea and response to treatment in a revascularized coronary artery disease cohort. 4994

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Polysomnographic characteristics and cardiac function in coronary artery disease patients with nonsleepy obstructive sleep apnoea
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018



Natural course of untreated obstructive sleep apnoea in patients with coronary artery disease in the RICCADSA trial
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



Cardiovascular outcomes in patients with coronary artery disease and nonsleepy versus sleepy obstructive sleep apnoea phenotypes in the RICCADSA trial
Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond
Year: 2021


Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP
Source: Eur Respir J, 50 (6) 1700749; 10.1183/13993003.00749-2017
Year: 2017



High prevalence of obstructive sleep apnoea in revascularized patients with coronary artery disease – RICCADSA trial
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008


Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up
Source: Eur Respir J 2006; 28: 596-602
Year: 2006



Influence of obstructive sleep apnea in coronary artery disease: an 8-years-follow-up
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003

Changes in extracranial arteries in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 69-74
Year: 2005



Late-breaking abstract: Cardiac function in a revascularized coronary artery disease cohort with obstructive sleep apnoea with and without daytime sleepiness in the RICCADSA trial
Source: Annual Congress 2011 - Obstructive sleep apnoea in children and adults
Year: 2011

Adherence to CPAP treatment in patients with coronary artery disease and obstructive sleep apnoea without sleepiness: a preliminary report from the riccadsa trial
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Association between obstructive sleep apnea syndrome and coronary atherosclerostic disease
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Increased incidence of coronary artery disease in obstructive sleep apnoea: a seven-year follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

Long-term effects of cardiac rehabilitation on sleep apnea severity in patients with coronary artery disease
Source: International Congress 2017 – CPAP therapy
Year: 2017


Obstructive sleep apnoea and coronary artery disease
Source: International Congress 2016 – PG18 Sleep apnoea and comorbidities
Year: 2016



Atherosclerosis of the carotid arteries in patients with COPD and obstructive sleep apnea (OSA).
Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea
Year: 2017

Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Systematic coronary risk evaluation among obstructive sleep apnea patients
Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing
Year: 2018


Heart rate turbulence: In patients with obstructive sleep apnea without coronary artery diseases
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011


Coronary plaque distribution and endothelial dysfunction in younger obstructive sleep apnea patients
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011


Prevalence and severity of obstructive sleep apnea syndrome in patients with atherosclerosis: A study using carotid ultrasonography and coronary angiography
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013